2024 Q3 Form 10-Q Financial Statement

#000149315224031255 Filed on August 12, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $938.4K
YoY Change 39.92%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $922.7K $938.4K
YoY Change 39.15% 39.92%
Operating Profit
YoY Change
Interest Expense $92.74K $111.6K
YoY Change 1047.43% 1424.08%
% of Operating Profit
Other Income/Expense, Net $93.78K $73.05K
YoY Change -873.25% 6535.15%
Pretax Income -$865.3K
YoY Change 29.24%
Income Tax
% Of Pretax Income
Net Earnings -$828.9K -$865.3K
YoY Change 22.76% 29.24%
Net Earnings / Revenue
Basic Earnings Per Share $0.03 $0.04
Diluted Earnings Per Share $0.03 $0.04
COMMON SHARES
Basic Shares Outstanding 26.48M shares 25.90M shares
Diluted Shares Outstanding 24.49M shares 23.93M shares

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $9.107M
YoY Change 1068.75%
Cash & Equivalents $7.399M $9.107M
Short-Term Investments
Other Short-Term Assets $543.4K
YoY Change 5410.75%
Inventory
Prepaid Expenses $518.1K $543.4K
Receivables
Other Receivables
Total Short-Term Assets $7.918M $9.650M
YoY Change -24.28% 1123.01%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $1.370M
YoY Change 66.64%
Other Assets
YoY Change
Total Long-Term Assets $2.871M $1.370M
YoY Change 257.99% 66.64%
TOTAL ASSETS
Total Short-Term Assets $7.918M $9.650M
Total Long-Term Assets $2.871M $1.370M
Total Assets $10.79M $11.02M
YoY Change -4.17% 583.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $808.3K
YoY Change -0.19%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.308M
YoY Change -0.12%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.308M
Total Long-Term Liabilities $0.00
Total Liabilities $1.277M $1.308M
YoY Change 0.36% -0.12%
SHAREHOLDERS EQUITY
Retained Earnings -$7.696M -$6.867M
YoY Change 77.85% 88.03%
Common Stock $2.651K $2.605K
YoY Change 50.8% 135.32%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $9.511M $9.712M
YoY Change
Total Liabilities & Shareholders Equity $10.79M $11.02M
YoY Change -4.17% 583.95%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income -$828.9K -$865.3K
YoY Change 22.76% 29.24%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$327.3K
YoY Change 146.11%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$475.0K
YoY Change
Cash From Investing Activities -$475.0K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 268.1K
YoY Change
NET CHANGE
Cash From Operating Activities -327.3K
Cash From Investing Activities -475.0K
Cash From Financing Activities 268.1K
Net Change In Cash -534.2K
YoY Change 301.71%
FREE CASH FLOW
Cash From Operating Activities -$327.3K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001605481
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-55600
dei Entity Registrant Name
EntityRegistrantName
NEVADA CANYON GOLD CORP.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-5152859
dei Entity Address Address Line1
EntityAddressAddressLine1
5655 Riggins Court
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 15
dei Entity Address City Or Town
EntityAddressCityOrTown
Reno
dei Entity Address State Or Province
EntityAddressStateOrProvince
NV
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
89502
dei City Area Code
CityAreaCode
(888)
dei Local Phone Number
LocalPhoneNumber
909-5548
dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value
dei Trading Symbol
TradingSymbol
NGLD
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
dei Amendment Flag
AmendmentFlag
false
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
NGLD Stockbased Compensation Investor Awareness And Marketing
StockbasedCompensationInvestorAwarenessAndMarketing
usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Other
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOther
shares
NGLD Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Warrants Issued In Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWarrantsIssuedInPeriodIntrinsicValue
dei Document Type
DocumentType
10-Q
dei Entity Listing Par Value Per Share
EntityListingParValuePerShare
0.0001
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
26477760 shares
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9744392 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
541034 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
10285426 usd
CY2023Q4 us-gaap Long Term Investments
LongTermInvestments
56105 usd
CY2023Q4 NGLD Mineral Property Interests And Royalty Interests
MineralPropertyInterestsAndRoyaltyInterests
780395 usd
CY2023Q4 us-gaap Assets
Assets
11121926 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
846307 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
460000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
1306307 usd
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
26055343 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
26055343 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25240051 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25240051 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
2523 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
14957547 usd
CY2023Q4 NGLD Obligation To Issue Shares
ObligationToIssueShares
18000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5162451 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
9815619 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11121926 usd
NGLD Investor Awareness Marketing
InvestorAwarenessMarketing
48518 usd
NGLD Consulting Fees
ConsultingFees
179493 usd
NGLD Director And Officer Compensation Expense
DirectorAndOfficerCompensationExpense
723506 usd
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
22272 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9258 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
38279 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
27047 usd
CY2024Q2 us-gaap Professional Fees
ProfessionalFees
7250 usd
CY2023Q2 us-gaap Professional Fees
ProfessionalFees
70320 usd
us-gaap Professional Fees
ProfessionalFees
27715 usd
us-gaap Professional Fees
ProfessionalFees
76320 usd
CY2024Q2 us-gaap Noninterest Expense Transfer Agent And Custodian Fees
NoninterestExpenseTransferAgentAndCustodianFees
4559 usd
CY2023Q2 us-gaap Noninterest Expense Transfer Agent And Custodian Fees
NoninterestExpenseTransferAgentAndCustodianFees
3868 usd
us-gaap Noninterest Expense Transfer Agent And Custodian Fees
NoninterestExpenseTransferAgentAndCustodianFees
15274 usd
us-gaap Noninterest Expense Transfer Agent And Custodian Fees
NoninterestExpenseTransferAgentAndCustodianFees
8590 usd
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
938382 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
670646 usd
us-gaap Operating Expenses
OperatingExpenses
1949090 usd
us-gaap Operating Expenses
OperatingExpenses
1063474 usd
CY2024Q2 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-38524 usd
CY2023Q2 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-6224 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
18674 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-94962 usd
CY2024Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-1 usd
CY2023Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
4 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-7 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
4 usd
CY2024Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
111578 usd
CY2023Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
7321 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
225649 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
13813 usd
CY2024Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
73053 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1101 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
244316 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-81145 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-865329 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-669545 usd
us-gaap Net Income Loss
NetIncomeLoss
-1704774 usd
us-gaap Net Income Loss
NetIncomeLoss
-1144619 usd
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23930830 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23930830 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
567053 usd
CY2023Q1 NGLD Stock Issued During Period Value Share Based Compensation For Consultants
StockIssuedDuringPeriodValueShareBasedCompensationForConsultants
38889 usd
CY2023Q1 NGLD Stock Issued During Period Value Share Based Compensation For Officers
StockIssuedDuringPeriodValueShareBasedCompensationForOfficers
58333 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
243733 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-475074 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
432934 usd
CY2023Q2 NGLD Stock Issued During Period Value Share Based Compensation For Consultants
StockIssuedDuringPeriodValueShareBasedCompensationForConsultants
116667 usd
CY2023Q2 NGLD Stock Issued During Period Value Share Based Compensation For Officers
StockIssuedDuringPeriodValueShareBasedCompensationForOfficers
175000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
246440 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-669545 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
301496 usd
CY2024Q1 NGLD Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
120840 usd
CY2024Q1 NGLD Stock Issued During Period Value To Be Issued On Exercise Of Warrants
StockIssuedDuringPeriodValueToBeIssuedOnExerciseOfWarrants
38850 usd
CY2024Q1 NGLD Stock Issued During Period Value Share Based Compensation For Consultants
StockIssuedDuringPeriodValueShareBasedCompensationForConsultants
116667 usd
CY2024Q1 NGLD Stock Issued During Period Value Share Based Compensation For Officers
StockIssuedDuringPeriodValueShareBasedCompensationForOfficers
175000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
245767 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-839445 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
9671674 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
9671674 usd
CY2024Q2 NGLD Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
258660 usd
CY2024Q2 NGLD Stock Issued During Period Value To Be Issued On Exercise Of Warrants
StockIssuedDuringPeriodValueToBeIssuedOnExerciseOfWarrants
10500 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Stock Issued Ownshare Lending Arrangement Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedOwnshareLendingArrangementIssuanceCosts
-1062 usd
CY2024Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
100275 usd
CY2024Q2 NGLD Stock Issued During Period Value Share Based Compensation For Consultants
StockIssuedDuringPeriodValueShareBasedCompensationForConsultants
116667 usd
CY2024Q2 NGLD Stock Issued During Period Value Share Based Compensation For Officers
StockIssuedDuringPeriodValueShareBasedCompensationForOfficers
175000 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
245767 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-865329 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
9712152 usd
us-gaap Net Income Loss
NetIncomeLoss
-1704774 usd
us-gaap Net Income Loss
NetIncomeLoss
-1144619 usd
NGLD Fair Value Loss Gain On Equity Investments
FairValueLossGainOnEquityInvestments
18674 usd
NGLD Fair Value Loss Gain On Equity Investments
FairValueLossGainOnEquityInvestments
-94962 usd
NGLD Stockbased Compensation Directors And Ceo
StockbasedCompensationDirectorsAndCeo
491534 usd
NGLD Stockbased Compensation Directors And Ceo
StockbasedCompensationDirectorsAndCeo
490173 usd
NGLD Stockbased Compensation Issued To Consultants
StockbasedCompensationIssuedToConsultants
233334 usd
NGLD Stockbased Compensation Issued To Consultants
StockbasedCompensationIssuedToConsultants
155556 usd
NGLD Stockbased Compensation Issued To Officer
StockbasedCompensationIssuedToOfficer
350000 usd
NGLD Stockbased Compensation Issued To Officer
StockbasedCompensationIssuedToOfficer
233333 usd
NGLD Stockbased Compensation Investor Awareness And Marketing
StockbasedCompensationInvestorAwarenessAndMarketing
100275 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
2325 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
5027 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-18040 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-15167 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-17031 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-568670 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-207820 usd
us-gaap Payments To Acquire Mineral Rights
PaymentsToAcquireMineralRights
495000 usd
us-gaap Payments To Acquire Mineral Rights
PaymentsToAcquireMineralRights
20000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-495000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-20000 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
428850 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
2686 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
426164 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-637506 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-227820 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
9744392 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1007018 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
9106886 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
779198 usd
NGLD Mineral Interests Acquired With Related Parties Payables Net
MineralInterestsAcquiredWithRelatedPartiesPayablesNet
40000 usd
NGLD Mineral Interests Acquired With Related Parties Payables Net
MineralInterestsAcquiredWithRelatedPartiesPayablesNet
20000 usd
us-gaap Nature Of Operations
NatureOfOperations
<p id="xdx_808_eus-gaap--NatureOfOperations_zMRo3G3kIFM7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 - <span id="xdx_82F_zBrVbq6F4DXk">NATURE OF BUSINESS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nevada Canyon Gold Corp. (the “Company”) was incorporated under the laws of the state of <span id="xdx_907_edei--EntityIncorporationStateCountryCode_c20240101__20240630_zWwS4bsERrp5" title="State of incorporation">Nevada</span> on <span id="xdx_90B_edei--EntityIncorporationDateOfIncorporation_dd_c20240101__20240630_zx4bAOTRt6hi" title="Date of incorporation">February 27, 2014</span>. On July 6, 2016, the Company changed its name from Tech Foundry Ventures, Inc. to Nevada Canyon Gold Corp. On December 15, 2021, the Company incorporated two subsidiaries, Nevada Canyon LLC and Canyon Carbon LLC. Both subsidiaries were incorporated under the laws of the state of Nevada. The Company is involved in acquiring and exploring mineral properties and royalty interests in Nevada and Idaho.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Going Concern</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s condensed consolidated financial statements are prepared using accounting principles generally accepted in the United States of America (“US GAAP”) applicable to a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company is in the business of acquiring and exploring mineral properties and royalty interests and has not generated or realized any revenues from these business operations. The ability of the Company to continue as a going concern is dependent on the Company obtaining adequate capital to fund operating losses until it becomes profitable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of June 30, 2024, the Company’s management has assessed the Company’s ability to continue as a going concern. Management’s assessment is based on various factors, including historical and projected financial performance, liquidity, and other relevant circumstances. As of the date of these condensed consolidated financial statements, the Company has sufficient cash to meet its working capital requirements and fund its exploration programs and general day-to-day operations for at least the next 12 months. This assessment takes into account the Company’s current cash balances as a result of the sale of the Company’s common shares under offering statement on Form 1-A (the “Offering”), and expected future cash inflows from the Offering and future financing the management is planning to undertake.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While the Company believes it has the financial resources to continue its operations for the next 12 months, it is important to note that there are inherent uncertainties in projecting future cash flows, and there can be no assurance that these projections will be realized. The Company continues to closely monitor its financial position, market conditions, and other factors that may impact its ability to continue as a going concern. Management’s assessment is based on the information available as of the date of this report. If unforeseen events, adverse market conditions, or other factors negatively affect the Company’s financial position in the future, there may be a need to adjust the going concern assessment. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. In the event that the Company’s ability to continue as a going concern becomes doubtful, adjustments to the carrying values of assets and liabilities, as well as additional disclosures, would be necessary.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2014-02-27
CY2024Q2 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
420767 usd
CY2023Q2 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
421440 usd
us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
841534 usd
us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
723506 usd
CY2024Q2 us-gaap Mineral Properties Net
MineralPropertiesNet
230395 usd
CY2023Q4 us-gaap Mineral Properties Net
MineralPropertiesNet
190395 usd
CY2024Q2 NGLD Royalty Interests
RoyaltyInterests
1065000 usd
CY2023Q4 NGLD Royalty Interests
RoyaltyInterests
590000 usd
CY2024Q2 NGLD Mineral Property Interests And Royalty Interests
MineralPropertyInterestsAndRoyaltyInterests
1295395 usd
CY2023Q4 NGLD Mineral Property Interests And Royalty Interests
MineralPropertyInterestsAndRoyaltyInterests
780395 usd
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
us-gaap Common Stock Voting Rights
CommonStockVotingRights
Voting rights are not cumulative and, therefore, the holders of more than 50% of the common stock could, if they chose to do so, elect all of the directors of the Company.
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
12349912 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue
1.20
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
12499343 shares
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue
1.20
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Other
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOther
124994 shares
CY2023 NGLD Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Warrants Issued In Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWarrantsIssuedInPeriodIntrinsicValue
1.20
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
363625 shares
NGLD Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised In Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodIntrinsicValue
1.20
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
274425 shares
CY2023 NGLD Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised In Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodIntrinsicValue
1.20
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
11986287 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue
1.20
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
12349912 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue
1.20
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
11986287 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P1Y3M14D
CY2024Q2 us-gaap Share Based Compensation
ShareBasedCompensation
537434 usd
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
538107 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1074868 usd
us-gaap Share Based Compensation
ShareBasedCompensation
879062 usd
CY2024Q2 NGLD Prepaid Investor Awareness Marketing
PrepaidInvestorAwarenessMarketing
500000 usd
CY2023Q4 NGLD Prepaid Investor Awareness Marketing
PrepaidInvestorAwarenessMarketing
500367 usd
CY2024Q2 NGLD Prepaid Filing And Listing Fees
PrepaidFilingAndListingFees
40734 usd
CY2023Q4 NGLD Prepaid Filing And Listing Fees
PrepaidFilingAndListingFees
38042 usd
CY2024Q2 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
2625 usd
CY2023Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
2625 usd
CY2024Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
543359 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
541034 usd

Files In Submission

Name View Source Status
0001493152-24-031255-index-headers.html Edgar Link pending
0001493152-24-031255-index.html Edgar Link pending
0001493152-24-031255.txt Edgar Link pending
0001493152-24-031255-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
ngld-20240630.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
ngld-20240630_cal.xml Edgar Link unprocessable
ngld-20240630_def.xml Edgar Link unprocessable
ngld-20240630_lab.xml Edgar Link unprocessable
ngld-20240630_pre.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending